References
- Flynn GL. Physicochemical determinants of skin absorption. In: Gerrity T, Henry C, eds. Principles of route-to-route extrapolation for risk assessment. New York: Elsevier; 1990:93–127.
- Degim IT. New tools and approaches for predicting skin permeability. Drug Discov Today 2006;11:517–523.
- Degim T, Hadgraft J, Ilbasmis S, Ozkan Y. Prediction of skin penetration using artificial neural network (ANN) modeling. J Pharm Sci 2003;92:656–664.
- Uchida T, Kadhum WR, Kanai S, et al. Prediction of skin permeation by chemical compounds using the artificial membrane, Strat-MTM. Eur J Pharm Sci 2015;67:113–118.
- Shah VP, Maibach HI. Topical drug bioavailability, bioequivalence and penetration. New York: Plenum Press; 1993.
- Pongjanyakul T. Permeation studies comparing cobra skin with human skin using nicotine transdermal patches. Drug Dev Ind Pharm 2000;26:635–642.
- Roberts ME, Mueller KR. Comparison of in-vitro nitroglycerin (TNG) aux across Yucatan pig, hairless mouse and human skin. Pharm Res 1990;7:444–453.
- Salerno C, Carlucci AM, Bregni C. Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms. AAPS Pharm Sci Tech 2010;11:986–993.
- Degim IT, Uslu A, Hadgraft J, et al. The effects of azone and capsaicin on the permeation of naproxen through human skin. Int J Pharm 1999;179:21–25.
- Todo H, Kimura E, Yasuno H, et al. Permeation pathway of macromolecules and nanospheres through skin. Biol Pharm Bull 2010;33:1394–1399.
- Ansari M, Kazemipour M, Aklamli M. The study of drug permeation through natural membranes. Int J Pharm 2006;327:6–11.
- Degim IT, Pugh WJ, Hadgraft J. Skin permeability data: anomalous results. Int J Pharm 1998;170:129–133.
- Li D, Kerns EH, Fan K, et al. High through-put artificial membrane permeability assay for blood brain barrier. Eur J Med Chem 2003;38:223–232.
- Duraje H, Tiwari AK, Gupta S. Simulation of skin permeability in chitosan membranes. Int J Pharm 2001;213:193–198.
- Gallagher SJ, Trottet L, Carter TP, Heard CM. Effects of membrane type and liquid/liquid phase boundary on in vitro release of ketoprofen from gel formulations. J Drug Target 2003;11:373–379.
- Iijima S. Helical microtubules of graphitic carbon. Nature 1991;354:56–58.
- Baughman RH, Zakhidov AA, Heer WA. Carbon nanotubes the route toward applications. Science 2002;297:787–792.
- Ericson LM, Fan H, Peng H, et al. Macroscopic, neat, single-walled carbon nanotube fibers. Science 2004;305:1447–1450.
- Milne WI, Teo KBK, Amaratunga GAJ, et al. Carbon nanotubes as field emission sources. J Mater Chem 2004;14:933–943.
- Martin CR, Kohli P. The emerging field of nanotube biotechnology. Nat Rev Drug Discov 2003;2:29–37.
- Bianco A, Prato M. Can carbon nanotubes be considered useful tools for biological applications? Adv Mater 2003;15:1765–1768.
- Shi Kam NW, Dai H. Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J Am Chem Soc 2005;127:6021–6026.
- Lin Y, Taylor S, Li H, et al. Advances toward bioapplications of carbon nanotubes. J Mater Chem 2004;14:527–541.
- Bianco A, Kostarelos K, Partidos CD, Prato M. Biomedical applications of functionalized carbon nanotubes. Chem Commun 2005;7:571–577.
- Kostarelos K, Lacerda L, Partidos CD, et al. Carbon nanotube-mediated delivery of peptides and genes to cells: translating nanobiotechnology to therapeutics. J Drug Deliv Sci Technol 2005;15:41–47.
- Bianco A. Carbon nanotubes for the delivery of therapeutic molecules. Expt Opin Drug Deliv 2004;1:57–65.
- Ilbasmis-Tamer S, Yilmaz Ş, Banoğlu E, Değim IT. Carbon nanotubes to deliver drug molecules. J Biomed Nanotechnol 2010;6:20–27.
- Degim IT, Burgess DJ, Papadimitrakopoulos F. Carbon nanotubes for transdermal drug delivery. J Microencapsul 2010;27:669–681.
- Bianco A, Kostarelos K, Prato M. Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 2005;9:674–679.
- Hinds BJ, Chopra N, Rantell T, et al. Aligned multiwalled carbon nanotube membranes. Science 2004;303:62–65.
- Kalra A, Garde S, Hummer G. Osmotic water transport through carbon nanotube membranes. PNAS 2003;100:10175–10180.
- Lattin GA, Padmanabhan RV, Phipps JB. Electronic control of iontophoretic drug delivery. Ann N Y Acad Sci 1991;618:450–464.
- Gangarosa LP, Park NH, Fong BC, et al. Conductivity of drugs used for iontophoresis. J Pharm Sci 1978;67:1439–1443.
- Kano S, Todo H, Sugie K, et al. Utilization of reconstructed cultured human skin models as an alternative skin for permeation studies of chemical compounds. Alter Animal Test Exp 2010;15:61–70.
- Morimoto Y, Hatanaka T, Sugibayashi K, Omiya H. Prediction of skin permeability of drugs: comparison of human and hairless rat skin. J Pharm Pharmacol 1992;44:634–639.
- Scott RC, Walker M, Dugard PH. A comparison of the in vitro permeability properties of human and some laboratory animal skins. Int J Cosmet Sci 1986;8:189–194.
- Potts RO, Guy RH. Predicting skin permeability. Pharm Res 1992;9:663–669.
- Degim T. Understanding skin penetration: computer aided modeling and data interpretation. Curr Comput-Aid Drug 2005;1:11–19.
- Bhusari VK, Dhaneshwar SR. Development of a validated stability-indicating HPLC assay method for dexketoprofen trometamol. Int J Pharm Pharm Sci 2012;4:321–326.
- Harde MT, Dharam DL, Jadhav SB, Balap AR. Development and validation of RP-HPLC method for simultaneous estimation of thiocolchicoside and dexketoprofen in bulk and tablet dosage form. Int J Pharm Tech Res 2012;4:1797–1802.
- Archana K, Vikas P. Development and validation of reversed phase high performance liquid chromatographic method for estimation of dexketoprofen trometamol in bulk and tablet dosage form. American J Phyto Clinic Ther 2013;4:395–400.
- Dhaneshwar SR, Jagtap VN. Development and validation of RP-HPLC-PDA method for simultaneous determination of dexketoprofen and thiocolchicoside in pharmaceutical dosage form. J Pharm Res 2013;6:604–608.
- Pavan Kumar VV, Vinu MCA, Ramani AV, et al. Simultaneous quantitation of etoricoxib, salicylic acid, valdecoxib, ketoprofen, nimesulide and celecoxib in plasma by high-performance liquid chromatography with UV detection. Biomed Chromatogr 2006;20:125–132.
- Matsuura H, Aoi A, Satou C, et al. Simultaneous UPLC MS/MS analysis of endogenous jasmonic acid, salicylic acid, and their related compounds. Plant Growth Regul 2009;57:293–301.
- Diez L, Livertoux MH, Stark AA, et al. High-performance liquid chromatographic assay of hydroxyl free radical using salicylic acid hydroxylation during in vitro experiments involving thiols. J Chromatogr B Biomed Sci App 2001;763:185–193.
- Gámiz-Gracia L, Luque de Castro MD. An HPLC method for the determination of vitamin B1, caffeine, acetylsalicylic acid and the impurities of salicylic acid in a pharmaceutical preparation. J Liq Chrom Rel Technol 1997;20:2123–2133.
- Dhaneshwar SR, Bhusari VK. Validated HPLC method for simultaneous quantitation of diclofenac sodium and misoprostol in bulk drug and formulation. Der Chemica Sinica 2010;1:110–118.
- Bhattacharyaa SS, Banerjeeb S, Ghosha AK, et al. A RP-HPLC method for quantification of diclofenac sodium released from biological macromolecules. Int J Biol Macromol 2013;58:354–359.
- Gowramma B, Rajan S, Muralidharan S, et al. A validated RP-HPLC method for simultaneous estimation of paracetamol and diclofenac potassium in pharmaceutical formulation. Int J Chem Tech Res 2010;2:676–680.
- Nasir F, Iqbal Z, Khan A, et al. Simultaneous determination of timolol maleate, rosuvastatin calcium and diclofenac sodium in pharmaceuticals and physiological fluids using HPLC-UV. J Chromatogr B 2011;879:3434–3443.
- Caon T, Costa ACO, Oliveira MAL, et al. Evaluation of the transdermal permeation of different paraben combinations through a pig ear skin model. Int J Pharm 2010;391:1–6.
- Degim Z. Prediction of permeability coefficients of compounds through Caco-2 cell monolayer using artificial neural network analysis. Drug Dev Ind Pharm 2005;31:935–942.
- Sinkó B, Garrigues TM, Balogh GT, et al. Skin–PAMPA: a new method for fast prediction of skin penetration. Eur J Pharm Sci 2012;45:698–707.
- Karadzovska D, Riviere JE. Assessing vehicle effects on skin absorption using artificial membrane assays. Eur J Pharm Sci 2013;50:569–576.
- Miki R, Ichitsuka Y, Yamada T, et al. Development of a membrane impregnated with a poly(dimethylsiloxane)/poly(ethylene glycol) copolymer for a high-throughput screening of the permeability of drugs, cosmetics, and other chemicals across the human skin. Eur J Pharm Sci 2015;66:41–49.
- Twist J, Zatz J. Membrane – solvent – solute interaction in a model permeation system. J Pharm Sci 1988;77:538–540.
- Corbo M, Schultz TW, Wong GK, Buskirk GA. Development and validation of in vitro release testing methods for semisolid formulations. Pharm Tech 1993;9:112–128.
- Pellett MA, Castellano S, Hadgraft J, Davis AF. The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro. J Control Release 1997;46:205–214.
- Siewert M, Dressman J, Brown CK, Shah VP. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS Pharm Sci Tech 2003;4. doi:10.1208/pt040107.
- Shah V, Elkins J, Williams R. Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products. Pharm Dev Technol 1999;4:377–385.
- Ueda CT, Shah VP, Derdzinski K, et al. Topical and transdermal drug products. Pharmacopeial Forum 2009;35:750–764.
- FDA-SUPAC-SS. Guidance for industry. SUPAC-SS non-sterile semisolid dosage forms. Scale-up and post approval changes: chemistry, manufacturing and controls. In Vitro Release Testing and In Vivo Bioequivalence Documentation 1997;19–24.
- Ng SF, Rouse J, Sanderson D, Eccleston G. A comparative study of transmembrane diffusion and permeation of ibuprofen across synthetic membranes using franz diffusion cells. Pharmaceutics 2010;2:209–223.
- Wu ST, Shiu GK, Simmons JE, et al. In vitro release of nitroglycerin from topical products by use artificial membranes. J Pharm Sci 1992;81:1153–1156.
- Garcia-Arieta A, Gordon J, Gwaza L, et al. Agitation rate and time for complete dissolution in BCS biowaivers based on investigation of a BCS biowaiver for dexketoprofen tablets. Mol Pharmaceutics 2015;12:3194–3201.
- Wu CY, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 2005;22:11–23.
- Chuasuwan B, Binjesoh V, Polli JE, et al. Biowaiver monographs for immediate release solid oral dosage forms: diclofenac sodium and diclofenac potassium. J Pharm Sci 2009;98:1206–1219.
- Majumder M, Chopra N, Andrews R, Hinds BJ. Nanoscale hydro-dynamics: enhanced flow in carbon nanotubes. Nature 2005;438:44.
- Hummer G, Rasaih JC, Noworyta JP. Water conduction through the hydrophobic channel of a carbon nanotube. Nature 2001;414:188–190.
- Agatonovic-Kustrin S, Beresford R, Pauzi A, Yusof M. ANN modeling of the penetration across a polydimethylsiloxane membrane from theoretically derived molecular descriptors. J Pharm Biomed Anal 2001;26:241–254.